Loading...
Multimodality therapy is recommended for limited-stage combined small cell esophageal carcinoma
BACKGROUND AND AIM: Limited-stage combined small cell esophageal carcinoma (LS-C-SCEC) is a rare, poorly understood, underdiagnosed disease, with components of both small cell esophageal cancer and non–small cell esophageal cancer. We investigated the optimal treatment strategy and prognostic factor...
Na minha lista:
| Udgivet i: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4335610/ https://ncbi.nlm.nih.gov/pubmed/25709477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S76048 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|